These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32667819)

  • 41. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
    Erhabor O; Azachi WB; Tosan E
    Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.
    Lu W; Ziman A; Yan MTS; Waters A; Virk MS; Tran A; Tang H; Shih AW; Scally E; Raval JS; Pandey S; Pagano MB; Shan H; Moore C; Morrison D; Cormack O; Fitzgerald J; Duncan J; Corean J; Clarke G; Yazer M
    Transfusion; 2023 Apr; 63(4):817-825. PubMed ID: 36815517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and Specificity of Red Blood Cell Alloantibodies in Patients from China During 1994-2013.
    Yu Y; Wang Y; Sun XL; Ma CY; Zhang XJ; Guan XZ; Chen LF; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1734-41. PubMed ID: 26708902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Haemolytic disease of the new-born by blood-factor incompatibility other than Rh(d) and ABO (author's transl)].
    Schellong G; Sandmann G; Fischer K; Poschmann A
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1591-7. PubMed ID: 824115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemolytic disease of the newborn caused by anti-Lan, anti-Jka, and anti-c.
    Shertz WT; Carty L; Wolford F
    Transfusion; 1987; 27(1):117. PubMed ID: 3101246
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemolytic disease of the fetus and newborn mediated by anti-Di
    Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
    Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-S Antibody: A Rare Cause of Fetal Hydrops in a Previously Sensitized Mother.
    Bakht A; Turner B; Warren CS; Simmons JH; Fadeyi EA
    Lab Med; 2021 Nov; 52(6):609-613. PubMed ID: 33900405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens.
    Christensen RD; Bahr TM; Ilstrup SJ; Dizon-Townson DS
    J Perinatol; 2023 Dec; 43(12):1459-1467. PubMed ID: 37848604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemolytic disease of the newborn due to anti-Kidd Jka sensitization during pregnancy].
    Mizutani T; Tanizawa O; Imai S; Suehara N; Takemura T; Wada Y; Fujita T; Kidoguchi K; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1587-90. PubMed ID: 2584811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.